Choi Kyeong Rok, Yu Hye Eun, Lee Hoseong, Lee Sang Yup
Metabolic and Biomolecular Engineering National Research Laboratory, Systems Metabolic Engineering and Systems Healthcare Cross-Generation Collaborative Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
BioProcess Engineering Research Center, KAIST, Daejeon, Republic of Korea.
Biotechnol Bioeng. 2022 Nov;119(11):3178-3193. doi: 10.1002/bit.28194. Epub 2022 Aug 4.
Heme has recently attracted much attention due to its promising applications in the food and healthcare industries. However, the current titers and productivities of heme produced by recombinant microorganisms are not high enough for a wide range of applications. In this study, the process for the fermentation of the metabolically engineered Escherichia coli HAEM7 strain was optimized for the high-level production of heme. To improve the production of heme, different carbon sources, iron concentration in the medium, pH control strategies, induction points, and iron content in the feeding solution were examined. Moreover, strategies of increasing cell density, regular iron supplementation, and supply of excess feeding solution were developed to further improve the production of heme. In the optimized fermentation process, the HAEM7 strain produced 1.03 g/L heme with productivity of 21.5 mg/L/h. The fermentation process and strategies reported here will expedite establishing industry-level production of heme.
由于血红素在食品和医疗保健行业具有广阔的应用前景,近年来备受关注。然而,目前重组微生物生产血红素的滴度和生产率还不够高,无法广泛应用。在本研究中,对代谢工程改造的大肠杆菌HAEM7菌株的发酵过程进行了优化,以实现血红素的高水平生产。为了提高血红素的产量,研究了不同的碳源、培养基中的铁浓度、pH控制策略、诱导点以及补料溶液中的铁含量。此外,还制定了提高细胞密度、定期补铁和供应过量补料溶液的策略,以进一步提高血红素的产量。在优化的发酵过程中,HAEM7菌株生产了1.03 g/L的血红素,生产率为21.5 mg/L/h。本文报道的发酵过程和策略将加快血红素工业化生产的建立。